Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Cold Genesys Inc.
DescriptionTumor-specific adenovirus vectors with GM-CSF transgene expression
Molecular Target Not applicable
Mechanism of ActionOncolytic virus
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPreclinical
Standard Indication Cancer (unspecified)
Indication DetailsTreat breast, ovarian, lung, colon and prostate cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today